Clinical trials
Phase 1 trials in Ukraine
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 9 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 8 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Recruiting | 11 |
| Terminated | 8 |
| Active, not recruiting | 6 |
| Unknown status | 1 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 6 |
| Merck Sharp & Dohme LLC | 4 |
| Lakefront Biotherapeutics NV | 3 |
| Amgen | 2 |
| Arbutus Biopharma Corporation | 2 |
| AstraZeneca | 2 |
| Hoffmann-La Roche | 2 |
| MacroGenics | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Alios Biopharma Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 7 |
| Arthritis, Rheumatoid | 6 |
| Colitis, Ulcerative | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Hepatitis B, Chronic | 4 |
| Lupus Erythematosus, Systemic | 4 |
| Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
Trials
Showing 51 to 68 of 68. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.